2005 Press Release

11.01.2005 Santen Announces Financial Results for the First Six Months ended September 30, 2005[PDF:17KB]

10.12.2005 Santen Receives Manufacturing and Marketing Approval for its Vernal Keratoconjunctivitis Treatment, PAPILOCK Mini Ophthalmic Solution 0.1%[PDF:39KB]

09.29.2005 Santen Establishes Subsidiary in China[PDF:29KB]

09.26.2005 Agreement Concerning CS-011 as Dry Eye Drug Candidate[PDF:18KB]

08.25.2005 Santen to Outsource its Logistics Operations [PDF:17KB]

08.12.2005 Santen's Car Including PC and Roster with Private Information Stolen[PDF:16KB]

07.29.2005 Financial Results for the First Quarter and Forecasts for FY2005 (Year ending March 2006)[PDF:500KB]

07.29.2005 Santen Announces Financial Results for the First Quarter of Fiscal Year 2005. (Three Months Ended June 30,2005)[Report]

07.07.2005 Santen Opens its Shanghai Representative Office [PDF:18KB]

07.04.2005 Notice on the Exercise Price of Stock Options (Stock Acquision Rights)[PDF:16KB]

06.24.2005 Notice on the Allotment of Stock Options (Stock Acquisition Rights)[PDF:16KB]

05.09.2005 Announcement on the New Management Organization [PDF:22KB]

05.09.2005 Santen to Issue Stock Acquisition Rights for the Purpose of Granting Stock Options [PDF:20KB]

05.09.2005 Santen to Issue Stock Acquisition Rights to the Directors for the Purpose of Granting Stock Options

05.09.2005 Santen Announces Financial Results for the Year ended March 31, 2005[PDF:19KB]

03.28.2005 Santen set up retirement benefit trust [PDF:17KB]

03.10.2005 Nara Institute of Science and Technology and Santen conclude agreement to establish Collaborative Course[PDF:31KB]

03.07.2005 Santen Announces Proposed Dividends Change [PDF:17KB]

01.31.2005 Santen Announces Financial Result for the Third Quarter of Fiscal Year 2004 ( Three Months Ended December 31, 2004) [Report]